Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DCAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C5orf56 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TTC38 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HARBI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CWC15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCXD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
SBF2-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGGY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXN3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOSPD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MADD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01089 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD3-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AAMDC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELMOD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on